๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Anticancer therapeutics: A surge of new developments increasingly target tumor and stroma

โœ Scribed by Henk J. Broxterman; Nafsika H. Georgopapadakou

Book ID
116413272
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
326 KB
Volume
10
Category
Article
ISSN
1368-7646

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Therapeutics targeting tumor immune esca
Therapeutics targeting tumor immune escape: Towards the development of new generation anticancer vaccines
โœ Simone Mocellin; Donato Nitti ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 482 KB

## Abstract Despite the evidence that immune effectors can play a significant role in controlling tumor growth under natural conditions or in response to therapeutic manipulation, it is clear that malignant cells evade immune surveillance in most cases. Considering that anticancer vaccination has r

KP1019, A New Redox-Active Anticancer Ag
KP1019, A New Redox-Active Anticancer Agent โ€“ Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients
โœ Christianโ€…G. Hartinger; Michaelโ€…A. Jakupec; Stefanie Zorbas-Seifried; Michael Gr ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 347 KB ๐Ÿ‘ 1 views

## Abstract The promising drug candidate indazolium __trans__โ€[tetrachlorobis(1__H__โ€indazole)ruthenate(III)] (KP1019) is the second Ruโ€based anticancer agent to enter clinical trials. In this review, which is an update of a paper from 2006 (__Hartinger etโ€…al., J. Inorg. Biochem.__ **2006**, __100_

ChemInform Abstract: KP1019, A New Redox
ChemInform Abstract: KP1019, A New Redox-Active Anticancer Agent โ€” Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients
โœ Christian G. Hartinger; Michael A. Jakupec; Stefanie Zorbas-Seifried; Michael Gr ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons โš– 16 KB ๐Ÿ‘ 1 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a โ€œFull Textโ€ option. The original article is trackable v